Aspen Aerogels (NYSE:ASPN) Releases FY 2025 Earnings Guidance

Key Points

• Aspen Aerogels has provided FY 2025 earnings guidance with an EPS estimate of -3.860 to -3.730, which is below the consensus estimate of -3.260.
• The company is projecting revenue between $297.0 million and $317.0 million, slightly higher than the consensus estimate of $296.5 million.
• Recent analyst reports include a downgrade by Oppenheimer to "market perform" and a reduced price target from Barclays to $7.00, which reflects growing skepticism about the stock's performance.

Aspen Aerogels (NYSE:ASPN - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of -3.860--3.730 for the period, compared to the consensus earnings per share estimate of -3.260. The company issued revenue guidance of $297.0 million-$317.0 million, compared to the consensus revenue estimate of $296.5 million.

Aspen Aerogels Stock Down 8.0%

Shares of ASPN stock traded down $0.61 during trading hours on Monday, hitting $6.95. 3,113,891 shares of the company were exchanged, compared to its average volume of 2,042,160. The business has a 50 day moving average of $6.72 and a two-hundred day moving average of $7.03. The company has a current ratio of 3.98, a quick ratio of 3.31 and a debt-to-equity ratio of 0.34. Aspen Aerogels has a 52 week low of $4.16 and a 52 week high of $33.15. The company has a market capitalization of $571.99 million, a PE ratio of -1.83 and a beta of 2.73.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.08. The company had revenue of $78.02 million during the quarter, compared to the consensus estimate of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The company's quarterly revenue was down 33.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.21 EPS. Analysts anticipate that Aspen Aerogels will post 0.17 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Barclays cut Aspen Aerogels from an "equal weight" rating to an "underweight" rating and upped their target price for the stock from $7.00 to $16.00 in a report on Monday. Oppenheimer cut Aspen Aerogels from an "outperform" rating to a "market perform" rating in a report on Thursday, May 8th. Finally, Canaccord Genuity Group lowered their target price on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a report on Friday. Two research analysts have rated the stock with a sell rating, two have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $19.50.

Institutional Investors Weigh In On Aspen Aerogels

Several large investors have recently modified their holdings of ASPN. Acadian Asset Management LLC purchased a new position in shares of Aspen Aerogels in the 1st quarter worth approximately $43,000. Integrated Wealth Concepts LLC purchased a new position in shares of Aspen Aerogels in the 1st quarter worth approximately $84,000. Creative Planning purchased a new position in shares of Aspen Aerogels in the 2nd quarter worth approximately $91,000. Caxton Associates LLP purchased a new position in shares of Aspen Aerogels in the 1st quarter worth approximately $307,000. Finally, Royal Bank of Canada grew its position in shares of Aspen Aerogels by 84.7% in the 1st quarter. Royal Bank of Canada now owns 56,419 shares of the construction company's stock worth $360,000 after buying an additional 25,880 shares during the last quarter. Institutional investors own 97.64% of the company's stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.